Clinical trials
Diabetes Mellitus, Type 2 trials in Qatar
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 5 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weill Cornell Medical College in Qatar | 6 |
| Weill Medical College of Cornell University | 4 |
| Hamad Medical Corporation | 2 |
| Dasman Diabetes Institute | 1 |
| Dr. Muhammad Abdulghani | 1 |
| Microclinic International | 1 |
| Novo Nordisk A/S | 1 |
| Primary Health Care Corporation, Qatar | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 17 |
| Obesity | 3 |
| Diabetes Mellitus | 2 |
| Acute Coronary Syndrome | 1 |
| Arthropathy, Neurogenic | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
| Chronic Disease | 1 |
| Glucose Intolerance | 1 |
| Hypertension | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.